Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.